Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Phase III, Multicenter, Randomized Trial

NCT01611766 is registered in ClinicalTrials.gov with Shanghai Gynecologic Oncology Group as lead sponsor.

NCT NCT01611766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01611766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Phase III, Multicenter, Randomized Trial
Lead sponsor
Shanghai Gynecologic Oncology Group
Phase
Phase 3
Overall status
Unknown status
Start date
July 19, 2012
Completion date
December 31, 2022
Enrollment
356 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube carcinoma, ovarian epithelial cancer recurrent, primary peritoneal carcinoma